EA201991105A1 - Методы оценки риска с использованием общей и специфической неклеточной днк - Google Patents
Методы оценки риска с использованием общей и специфической неклеточной днкInfo
- Publication number
- EA201991105A1 EA201991105A1 EA201991105A EA201991105A EA201991105A1 EA 201991105 A1 EA201991105 A1 EA 201991105A1 EA 201991105 A EA201991105 A EA 201991105A EA 201991105 A EA201991105 A EA 201991105A EA 201991105 A1 EA201991105 A1 EA 201991105A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- total
- specific non
- risk assessment
- cellular dna
- assessment methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2560/00—Nucleic acid detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Настоящее изобретение относится к способам и композициям для оценки риска путем определения уровней общих и специфических неклеточных нуклеиновых кислот (таких как ДНК) у индивидуума. Описанные здесь способы и композиции могут быть применены для определения риска развития такого состояния, как отторжение трансплантата.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662416689P | 2016-11-02 | 2016-11-02 | |
PCT/US2017/030293 WO2017190106A1 (en) | 2016-04-29 | 2017-04-29 | Multiplexed optimized mismatch amplification (moma)-target number |
PCT/US2017/059808 WO2018085603A1 (en) | 2016-11-02 | 2017-11-02 | Methods for assessing risk using total and specific cell-free dna |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201991105A1 true EA201991105A1 (ru) | 2020-01-27 |
Family
ID=62076613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201991105A EA201991105A1 (ru) | 2016-11-02 | 2017-11-02 | Методы оценки риска с использованием общей и специфической неклеточной днк |
Country Status (10)
Country | Link |
---|---|
US (1) | US20190367972A1 (ru) |
EP (1) | EP3535413A1 (ru) |
JP (1) | JP2019534016A (ru) |
CN (1) | CN110114477A (ru) |
AU (1) | AU2017355464A1 (ru) |
CA (1) | CA3042696A1 (ru) |
EA (1) | EA201991105A1 (ru) |
IL (1) | IL266382A (ru) |
MX (1) | MX2019005199A (ru) |
WO (1) | WO2018085603A1 (ru) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9424392B2 (en) | 2005-11-26 | 2016-08-23 | Natera, Inc. | System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals |
US10316362B2 (en) | 2010-05-18 | 2019-06-11 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US11339429B2 (en) | 2010-05-18 | 2022-05-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11332785B2 (en) | 2010-05-18 | 2022-05-17 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11322224B2 (en) | 2010-05-18 | 2022-05-03 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11408031B2 (en) | 2010-05-18 | 2022-08-09 | Natera, Inc. | Methods for non-invasive prenatal paternity testing |
US11939634B2 (en) | 2010-05-18 | 2024-03-26 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CA2798758C (en) | 2010-05-18 | 2019-05-07 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
US11326208B2 (en) | 2010-05-18 | 2022-05-10 | Natera, Inc. | Methods for nested PCR amplification of cell-free DNA |
US9677118B2 (en) | 2014-04-21 | 2017-06-13 | Natera, Inc. | Methods for simultaneous amplification of target loci |
US20190010543A1 (en) | 2010-05-18 | 2019-01-10 | Natera, Inc. | Methods for simultaneous amplification of target loci |
CA2824387C (en) | 2011-02-09 | 2019-09-24 | Natera, Inc. | Methods for non-invasive prenatal ploidy calling |
CN113774132A (zh) | 2014-04-21 | 2021-12-10 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
EP3294906B1 (en) | 2015-05-11 | 2024-07-10 | Natera, Inc. | Methods for determining ploidy |
WO2018067517A1 (en) | 2016-10-04 | 2018-04-12 | Natera, Inc. | Methods for characterizing copy number variation using proximity-litigation sequencing |
US20190360033A1 (en) * | 2016-11-02 | 2019-11-28 | The Medical College Of Wisconsin, Inc. | Methods for assessing risk using mismatch amplification and statistical methods |
US10011870B2 (en) | 2016-12-07 | 2018-07-03 | Natera, Inc. | Compositions and methods for identifying nucleic acid molecules |
JP2020524519A (ja) * | 2017-06-20 | 2020-08-20 | ザ メディカル カレッジ オブ ウィスコンシン,インコーポレイテッドThe Medical College of Wisconsin, Inc. | 全セルフリーdnaによる移植合併症リスクの評価 |
JP2021520816A (ja) | 2018-04-14 | 2021-08-26 | ナテラ, インコーポレイテッド | 循環腫瘍dnaの個別化された検出を用いる癌検出およびモニタリングの方法 |
WO2019217918A1 (en) * | 2018-05-10 | 2019-11-14 | The Medical College Of Wisconsin, Inc. | Multiplexed optimized mismatch amplification (moma)-cancer risk assessment with non-cancer associated targets |
US11525159B2 (en) | 2018-07-03 | 2022-12-13 | Natera, Inc. | Methods for detection of donor-derived cell-free DNA |
US11931674B2 (en) | 2019-04-04 | 2024-03-19 | Natera, Inc. | Materials and methods for processing blood samples |
WO2021207244A1 (en) * | 2020-04-06 | 2021-10-14 | The Medical College Of Wisconsin, Inc. | Methods for assessing the severity of, and for inhibiting, pro-inflammatory responses with total cell-free dna |
WO2022182878A1 (en) * | 2021-02-25 | 2022-09-01 | Natera, Inc. | Methods for detection of donor-derived cell-free dna in transplant recipients of multiple organs |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2013509883A (ja) * | 2009-11-06 | 2013-03-21 | ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ | 臓器移植患者における移植片拒絶反応の非侵襲的診断方法 |
JP5842811B2 (ja) * | 2010-03-24 | 2016-01-13 | 凸版印刷株式会社 | 競合プライマーによる標的塩基配列の検出方法 |
US10131947B2 (en) * | 2011-01-25 | 2018-11-20 | Ariosa Diagnostics, Inc. | Noninvasive detection of fetal aneuploidy in egg donor pregnancies |
WO2013159035A2 (en) * | 2012-04-19 | 2013-10-24 | Medical College Of Wisconsin, Inc. | Highly sensitive surveillance using detection of cell free dna |
US20140242582A1 (en) | 2013-02-28 | 2014-08-28 | Ariosa Diagnostics, Inc. | Detection of genetic abnormalities using ligation-based detection and digital pcr |
WO2014194113A2 (en) * | 2013-05-29 | 2014-12-04 | Chronix Biomedical | Detection and quantification of donor cell-free dna in the circulation of organ transplant recipients |
DK3117012T3 (da) * | 2014-03-14 | 2019-05-13 | Caredx Inc | Fremgangsmåder til overvågning af immunosuppressive terapier hos en transplantmodtager |
CA2985134A1 (en) * | 2014-05-09 | 2015-11-12 | Sebastian Gromminger | Detection of dna that originates from a specific cell-type and related methods |
US10435750B2 (en) * | 2014-07-03 | 2019-10-08 | Multiplicom N.V. | Methods for non-invasive detection of transplant health or rejection |
US10704104B2 (en) * | 2014-10-20 | 2020-07-07 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for screening a subject for a cancer |
WO2016123698A1 (en) * | 2015-02-06 | 2016-08-11 | Uti Limited Partnership | Diagnostic assay for post-transplant assessment of potential rejection of donor organs |
AU2016255573A1 (en) * | 2015-04-30 | 2017-12-21 | The Medical College Of Wisconsin, Inc. | Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing cell-free DNA |
CN109661476A (zh) * | 2016-04-29 | 2019-04-19 | 威斯康星州立大学医学院 | 用于评估胎儿健康的多重优化错配扩增(moma)实时pcr |
-
2017
- 2017-11-02 CA CA3042696A patent/CA3042696A1/en not_active Abandoned
- 2017-11-02 EP EP17808237.6A patent/EP3535413A1/en active Pending
- 2017-11-02 CN CN201780081587.5A patent/CN110114477A/zh active Pending
- 2017-11-02 JP JP2019523590A patent/JP2019534016A/ja active Pending
- 2017-11-02 US US16/347,180 patent/US20190367972A1/en not_active Abandoned
- 2017-11-02 MX MX2019005199A patent/MX2019005199A/es unknown
- 2017-11-02 WO PCT/US2017/059808 patent/WO2018085603A1/en unknown
- 2017-11-02 AU AU2017355464A patent/AU2017355464A1/en not_active Abandoned
- 2017-11-02 EA EA201991105A patent/EA201991105A1/ru unknown
-
2019
- 2019-05-01 IL IL266382A patent/IL266382A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2019005199A (es) | 2019-10-14 |
CN110114477A (zh) | 2019-08-09 |
WO2018085603A1 (en) | 2018-05-11 |
IL266382A (en) | 2019-06-30 |
JP2019534016A (ja) | 2019-11-28 |
EP3535413A1 (en) | 2019-09-11 |
US20190367972A1 (en) | 2019-12-05 |
AU2017355464A1 (en) | 2019-05-30 |
CA3042696A1 (en) | 2018-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201991105A1 (ru) | Методы оценки риска с использованием общей и специфической неклеточной днк | |
EA201892489A1 (ru) | Число мишеней для мультиплексной оптимизированной амплификации с несоответствиями (moma) | |
EA201792389A1 (ru) | Пцр в реальном времени для мультиплексной оптимизированной амплификации с несоответствиями (moma) и для оценки неклеточной днк | |
EA201992001A1 (ru) | Композиции и способы повышения экспрессии генов | |
BR112017017025A2 (pt) | métodos e composições para analizar componentes celulares | |
BR112018002848A2 (pt) | método, aparelho, mídia de armazenamento não transitório, programa de computador, kit para medir níveis de expressão de seis ou mais genes-alvo da via de sinalização celular | |
EA201890619A1 (ru) | КОМПОЗИЦИИ iRNA ЛИГАНДА 1 БЕЛКА ЗАПРОГРАММИРОВАННОЙ ГИБЕЛИ КЛЕТОК 1 (PD-L1) И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
EA201692157A1 (ru) | Синтез двухцепочечных нуклеиновых кислот | |
EA201790769A1 (ru) | Определение уровней гликозаминогликанов методом масс-спектрометрии | |
EA201791184A1 (ru) | Днк-примеси в композиции, содержащей парвовирусный вирион | |
MX2020001809A (es) | Metodos para determinar acido desoxirribonucleico circulante de donante sin genotipo de donante. | |
AR105618A1 (es) | Metilación del promotor del ligando al receptor de muerte programada (pd-l1) en cáncer | |
DK3138489T3 (da) | Sæt til bestemmelse af en analytkoncentration | |
EA201792080A1 (ru) | Гуманизированные анти-c1s антитела и способы их применения | |
EA201892491A1 (ru) | Пцр в реальном времени с мультиплексной оптимизированной амплификацией неправильно спаренных оснований (moma) для анализа злокачественных новообразований | |
MX2016016742A (es) | Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv). | |
WO2017044993A3 (en) | Nucleic acid analysis by joining barcoded polynucleotide probes | |
BR112017023473A2 (pt) | método de detecção e quantificação de ácido nucleico e composições | |
BR112014026440A2 (pt) | assays, methods and apparatus for assessing rna disruption | |
EA201991506A1 (ru) | Системы и способы для тестирования и скрининга с использованием связанных с соединениями субстратов | |
EA201891478A1 (ru) | Способы и композиции для оценки риска возникновения рака | |
EA201691702A1 (ru) | Химерные белки мти | |
AR104805A1 (es) | Métodos y composiciones para evaluar la capacidad de respuesta de los cánceres a los inhibidores de bet | |
MX2019011702A (es) | Ensayos de inmunogenicidad mejorados. | |
DK3207374T3 (da) | Fremgangsmåde og system til bestemmelse af koncentrationen af en analyt i en fluidprøve |